Learn, Analyse & Invest
only with
only with
+91
Download Orca
Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Phar
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Mid-cap - With a market cap of ₹439.00 Cr.
Financial Strength
Stable
Ratios Analysis
Balance Sheet
Results Analysis
Cash Flow
Profit Loss
Key Metrics
Market Capitalisation
₹ 43899.88 Cr.
Enterprise Value
₹ 43175 Cr.
Shares Outstanding
16.94 Cr.
Dividend Yield
2.08%
Face Value
₹ 10
Book Value
₹ 100.52
TTM EPS
55.99 Cr.
TTM-PE
46.29
Latest Equity
169.41
Latest Reserve
₹ 1533
Peers Comparison
| Stocks | CMP (₹) | Mark. Cap Size | P/E | P/B | EPS | ROE |
|---|---|---|---|---|---|---|
| Astrazeneca Pharma I | Loading... | Small-cap | 185.9 | 28.19 | 46.3 | 15.73 |
| Ajanta Pharma | Loading... | Mid-cap | 35.53 | 8.64 | 73.69 | 25.06 |
| Ipca Laboratories | Loading... | Mid-cap | 51.63 | 5.48 | 29.08 | 11.86 |
| Pfizer | Loading... | Small-cap | 23.86 | 4.34 | 167.78 | 19.65 |
